REG - Yourgene Health PLC - Appointment of Sole Corporate Broker

Yourgene HealthAnnouncement

17/04/2019 16:55

RNS Number : 5400W
Yourgene Health PLC
17 April 2019
 


Yourgene Health plc
("Yourgene" or the "Company")
 
Appointment of Sole Corporate Broker
 
Manchester, UK - 17 April 2019: Yourgene Health (AIM: YGEN), the international molecular diagnostics group which commercialises genetic products and services, announces the appointment of Stifel Nicolaus Europe Limited as the Company's Sole Corporate Broker with immediate effect.
 
 
 




For more information, please contact:
 


 




Yourgene Health plc
Lyn Rees, Chief Executive Officer
Barry Hextall, Chief Financial Officer
Joanne Cross, Head of Marketing
investors@yourgene-health.com
 


Tel: +44 (0)161 667 1053
 
 




Cairn Financial Advisers LLP (NOMAD)
Liam Murray / James Caithie / Ludovico Lazzaretti
 


Tel: +44 (0)20 7213 0880




Stifel Nicolaus Europe Limited (Sole Corporate Broker)
Nicholas Moore / Matthew Blawat / Ben Maddison
 


Tel: +44 (0)20 7710 7600




Vigo Communications
Ben Simons / Fiona Henson / Antonia Pollock
yourgene@vigocomms.com


Tel: +44 (0)20 7390 0238
 




 
 
About Yourgene Health
Yourgene Health is an international molecular diagnostics group which develops and commercialises genetic products and services. The group works in partnership with global leaders in DNA technology to advance diagnostic science. 
 
Our product development, research service and commercial capabilities extend across the lifecycle of genetic test development including regulatory submissions.
 
Yourgene Health's first commercialised products are non-invasive prenatal tests (NIPT) for Down's syndrome and other genetic disorders, targeting a share of an emerging billion-dollar global market.
 
Prenatal screening is an established clinical practice, but accuracy challenges with traditional methods are driving the need for NIPT and other DNA-based reproductive health testing solutions. Yourgene Health's customer-focused products and services support all types of customer, irrespective of size, geography and market maturity. Our commercial footprint is already established in the UK, Europe, the Middle East, Africa and Asia.
 
Through our technical expertise and partnerships, Yourgene Health is aiming to extend its genetic testing offering into complementary areas of reproductive health and oncology.
 
Yourgene Health is headquartered in Manchester, UK with offices in Taipei and Singapore. For more information visit www.yourgene-health.com and follow us on twitter @Yourgene_Health.
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
APPEDLFFKZFLBBF